Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Probiotic Sinus Irrigations for Chronic Rhinosinusitis
NCT05427695Phase 2Recruiting
- Sponsor
- University of Illinois Chicago
- Start
- Feb 2025
- Primary completion
- Mar 2028
- Modality
- Yeast Strains, Defined Consortia, Bacterial Strains
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Lactobacillus sakei in chronic rhinosinusitis (CRS) (2 arms), sponsored by University of Illinois Chicago. Primary endpoint: Sinonasal Outcome Test-22 at 6 weeks. Started Feb 2025; status: recruiting.
02
Drugs
Lactobacillus sakei
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on NCT05427695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05427695.